Close-up of the Ammalife PPH Detection Drape collection pouch and calibrated measurement scale.

Working with Ammalife to improve maternal outcomes

10th November 2026

Bringing together clinical research, practical innovation and a shared commitment to improving maternity care.

Maternity by Kimal is proud to be working in partnership with Ammalife, a UK-based maternal health charity, to support earlier recognition of postpartum haemorrhage (PPH) and help improve outcomes for women giving birth in the UK and internationally.

The collaboration brings together Kimal’s medical device expertise and established healthcare partnerships with Ammalife’s research and clinical knowledge, helping translate evidence into practical solutions for maternity teams.

At the centre of the partnership is the Ammalife PPH Detection Drape, developed to support objective measurement of blood loss during childbirth and enable clinicians to recognise excessive bleeding and respond promptly.

Addressing a critical challenge in maternity care

Postpartum haemorrhage remains a leading cause of maternal mortality worldwide. Early recognition and timely treatment are essential, yet traditional visual estimation of blood loss can be inaccurate, potentially delaying the identification of excessive bleeding.

The importance of objective blood loss measurement was demonstrated in the E-MOTIVE trial, published in the New England Journal of Medicine in 2023.

In hospitals in Kenya, Nigeria, South Africa and Tanzania, early detection using a calibrated blood collection drape, combined with a bundle of recommended treatments and an implementation strategy, reduced the composite outcome of severe postpartum haemorrhage, laparotomy for bleeding or maternal death from bleeding by 60% compared with usual care. This was a result for the combined approach, rather than the drape alone. Read the E-MOTIVE trial.

Building on the evidence underpinning this approach, the Ammalife PPH Detection Drape was developed with input from UK clinical teams to provide a practical solution suitable for different maternity care settings.

From clinical evidence to everyday practice

The Ammalife PPH Detection Drape positioned below a bed, showing its collection pouch and measurement scale.
The Ammalife PPH Detection Drape and its calibrated collection pouch.

With over 20 NHS trusts now purchasing the Ammalife PPH Detection Drape through Maternity by Kimal, our partnership with Ammalife continues to support access to objective blood loss measurement in maternity care.

The drape has an integrated calibrated collection pouch with clear measurement markers to support clinicians in objectively monitoring blood loss during and immediately after childbirth.

The World Health Organization’s 2025 consolidated PPH guidelines recommend routine objective measurement of postpartum blood loss to improve detection and prompt treatment.

Stacey Tyler, Maternity Business Unit Manager at Kimal, explains:

“We saw an opportunity to address a clear clinical need with a simple, practical, evidence-based product. When a woman is bleeding after birth, clinicians need clear information to help them recognise excessive blood loss and respond. The drape is designed to support exactly that.”

A partnership with a wider purpose

Beyond supporting maternity services, the partnership also contributes to Ammalife’s wider mission to improve maternal health globally.

For every Ammalife PPH Detection Drape sold in the UK, Kimal makes a donation to the charity, helping support its ongoing work in maternal health research, education and practical interventions, particularly in lower-resource settings. Read Ammalife’s account of the partnership.

Stacey Tyler adds:

“We believe every woman deserves to give birth safely, wherever she lives. That’s why we’re proud to support Ammalife and its work to make that a reality for more women and their families. By bringing our manufacturing and commercial experience together with Ammalife’s research and clinical expertise, we can help make a practical, evidence-based product more widely available. It’s a partnership that puts our shared commitment to safer maternity care into practice.”

Maternity by Kimal and Ammalife share a goal of supporting maternity professionals to recognise and respond to PPH earlier, while helping improve maternal health outcomes around the world.

Find out more

Discover the Ammalife PPH Detection Drape or contact our maternity specialists at maternity@kimal.com to learn more about supporting objective blood loss measurement in your maternity service.

To learn more about the charity and its work, visit Ammalife.

References

  1. Gallos ID et al. Randomized Trial of Early Detection and Treatment of Postpartum Hemorrhage. New England Journal of Medicine. 2023;389:11-21.
  2. World Health Organization, FIGO and ICM. Consolidated guidelines for the prevention, diagnosis and treatment of postpartum haemorrhage. 2025.